Skip to content

Clinical study of acupuncture treatment of prehypertension with anxiety state based on the theory of harmonization of liver and spleen

Clinical study of acupuncture treatment of prehypertension with anxiety state based on the theory of harmonization of liver and spleen

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200067019
Enrollment
Unknown
Registered
2022-12-23
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical hypertension

Interventions

Treatment group :acupuncture

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. No antihypertensive drugs were taken in the past 4 weeks and the upper brachial artery sitting blood pressure, systolic blood pressure (SBP) of 120-139mmHg and/or diastolic blood pressure (DBP) of 80-89mmHg were measured for 3 consecutive times on different days within 1 week; 2. HAMA scores >= 14 and <= 29; 3. Aged 18-50 years, gender unlimited; 4. It meets the diagnostic criteria of liver depression and spleen deficiency; 5. Volunteer to participate and cooperate with the researcher by signing a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with definite primary and secondary hypertension; 2. Borderline hypertension patients taking Western antihypertensive drugs; 3. Patients with acute or severe cerebrovascular diseases such as cerebral hemorrhage, subarachnoid hemorrhage, cerebral infarction and transient ischemic attack; 4. Patients with acute coronary syndrome, acute onset of chronic heart failure, malignant arrhythmia, valvular heart disease, cardiomyopathy and other serious cardiovascular diseases; 5. Pregnant and lactating women; 6. Patients with severe liver and kidney dysfunction who were determined by the researchers not to be included in the group; 7. Patients who have taken anti-anxiety medication in the last six months; 8. Patients with language or mental disorders, mental illness and other patients can not accurately describe their symptoms and understand the content of the questionnaire; 9. Patients with other bleeding diseases or intolerance to acupuncture.

Design outcomes

Primary

MeasureTime frame
Immediate blood pressure before and after acupuncture;

Secondary

MeasureTime frame
Ambulatory blood pressure Mean blood pressure;TCM syndrome score;Serum HYC, CRP, TG, TC, HDL, LDL, PRA, ALD levels;The serum levels of nitric oxide(NO), superoxide dismutase (SOD), angiotensinII(AngII),calmodulin(CaM),hippocampal monoamine transmitter 5-hydroxytryptamine(5-HT) and dopamine(DA);Changes in the contents of NF-kB, Myd88, TLR4, IL-6, TNF-a, NLRP3, SIRT1, IL-1ß and IL-18 in venous blood;

Countries

China

Contacts

Public ContactXiaoyang Lu

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

luxiaoyang_1030@163.com+86 176 1089 1030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026